Navigation Links
Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome
Date:1/15/2014

ences.  Key hormones, including adiponectin and leptin, also showed changes characteristic of non-PWS obese patients, demonstrating that the drug was highly active in these patients and had a similar effect to that seen in non-PWS patients.

"These results are very exciting for the treatment of PWS, as most patients showed improvements in body weight, hunger-related behaviors, and body fat content, despite the increased food intake included in the trial design," explained Dr. Jennifer Miller, Associate Professor of Pediatric Endocrinology, University of Florida, and Principal Investigator for the study.  "PWS is a complex genetic disease that is difficult to treat and the results of this trial demonstrate that beloranib has a beneficial impact on this underserved patient population.  Notably, we were encouraged by reports of fullness, a first-time occurrence for PWS patients who otherwise lack the capacity to feel sated after meals."

"PWS patients remain severely impacted by their disease and are not treatable with other anti-obesity agents," added Janalee Heinemann, Director of Research & Medical Affairs for the Prader-Willi Syndrome Association (USA).  "PWS represents one of the most severe forms of genetic obesity and we welcome these results, which are a significant step towards finding a treatment for those suffering from this life threatening condition."

Beloranib, a novel obesity therapy that utilizes a unique mechanism of action, is being studied for its ability to reduce body weight and improve cardiometabolic risk factors in obese patients with and without PWS.  This study was a randomized, double-blind, placebo-controlled trial to evaluate the safety and tolerability of a dose range of beloranib administered as twice-weekly subcutaneous injections for four weeks.  The randomized treatment part of the study was follow
'/>"/>

SOURCE Zafgen, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Zafgen Announces Initiation of Phase 2a Clinical Development with Beloranib in Obesity
2. Zafgen Secures $21 Million in Series D Financing
3. Zafgen Announces New Weight Loss and Safety Data from Phase 2 Study of Beloranib in Obesity at Obesity Week 2013
4. Zafgen Secures $45 Million in Series E Financing
5. Zafgen Appoints Chief Commercial Officer and New Member of Board of Directors
6. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
7. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
8. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
9. Misonix Announces New Distribution Agreement For Panama
10. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
11. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... , April 1, 2015  Egalet Corporation (Nasdaq: ... pharmaceutical company focused on developing, manufacturing and marketing ... an offering of $60.0 million aggregate principal amount ... "notes") in a private placement to qualified institutional ... Act of 1933, as amended (the "Act"). Egalet ...
(Date:4/1/2015)... 2015  Boston Scientific Corporation (NYSE: BSX ) will ... 8 a.m. ET to review financial results and business highlights ... news release announcing first quarter financial results prior to the ... Mike Mahoney , president and chief executive officer, and ... officer. A live webcast of the conference call ...
(Date:4/1/2015)... , April 1, 2015 CSSi, ( ... for the clinical research industry, recently partnered with ... dermatology study that was falling quickly behind their ... and customized site support programs, increased the number ... and also increased the number of sites actively ...
Breaking Medicine Technology:Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 2Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 3Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 4Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 5Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 6Egalet Announces Pricing of $60 Million Offering of Convertible Senior Notes Due 2020 7Boston Scientific To Webcast Conference Call On First Quarter 2015 Financial Results 2CSSi Quadruples Screening Activity and Speeds Enrollment for Pediatric Dermatology Study 2
... 2012 Zimmer Holdings, Inc. (NYSE: ZMH ; ... it will be participating in the Bank of America Merrill ... Las Vegas in Nevada, on May 16, 2012, at 10:00 ... the presentation can be accessed via Zimmer,s Investor Relations website ...
... 12, 2012  Qualitest Pharmaceuticals today announced that the U.S. ... 100mg/mL. Qualitest plans to begin distribution in mid-2012. ... 100mg/mL, in the U.S. for the 12 months ending ... IMS Health. About Qualitest ...
Cached Medicine Technology:Zimmer Holdings to Present at the Bank of America Merrill Lynch 2012 Health Care Conference 2
(Date:4/1/2015)... OSF Saint Paul Medical Center, the newest member ... into the Ministry April 1, 2015, with a Blessing ... vicar general of the Catholic Diocese of Peoria. ... year-long transition process for the former Mendota Community Hospital, ... morning ceremony included Sister Judith Ann Duvall, O.S.F., Chairperson, ...
(Date:4/1/2015)... CA (PRWEB) April 01, 2015 ... senior care, today announces the launch of the ... innovative senior care stakeholders and technology companies. The announcement ... Center (NIC) Capital and Business Strategies Forum in ... members, the new Alliance program is now open for ...
(Date:4/1/2015)... Texas (PRWEB) April 01, 2015 ... and Distinguished Teaching Professor of the Department of ... with other doctors to review reports of blindness resulting ... cosmetic surgery . The group published their study, along ... and Reconstructive Surgery journal. , "We began to see ...
(Date:4/1/2015)... 2015 EB Medicine, leading publisher ... Medicine Practice, and Hospital Medicine Practice, is pleased ... to provide the content from its flagship publication, ... application format available on iPhones, iPads and Android ... AgileMD to develop mobile applications for EB Medicine’s ...
(Date:4/1/2015)... Skin cancer is one of the most common ... Forefront Dermatology and Dermatology Associates of Wisconsin want to ensure ... spreads so they are hosting a free skin cancer screening ... 12:30pm. , “If we can see the early warning ... could become cancerous,” said Dr. Ken Katz, who is the ...
Breaking Medicine News(10 mins):Health News:Mendota Community Hospital Now OSF Saint Paul Medical Center 2Health News:Mendota Community Hospital Now OSF Saint Paul Medical Center 3Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 2Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 3Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 4Health News:Dr. Rod J. Rohrich and Colleagues Study Rare Occurrences of Blindness Caused by Use of Facial Fillers 2Health News:Dr. Rod J. Rohrich and Colleagues Study Rare Occurrences of Blindness Caused by Use of Facial Fillers 3Health News:EB Medicine Partners With AgileMD on Mobile Application for Emergency Medicine Clinicians 2Health News:EB Medicine Partners With AgileMD on Mobile Application for Emergency Medicine Clinicians 3Health News:Forefront Dermatology and Dermatology Associates of Wisconsin Offers Skin Cancer Screenings on April 11th 2
... , , American ... , s Water and Wastewater Infrastructure Systems , ... Americans, we owe our health and much of our quality of life ... the drinking water and wastewater systems on which we rely. Despite the ...
... , Conference Led by John Iglehart to Inform Policy Recommendations ... , WASHINGTON, July 15 Health reform ... reduce the barriers to proper medication adherence, many patients will not experience improved ... , , Although the evidence on poor adherence ...
... 15 Trends in the economy and the medical industry have ... assignments. This matches perfectly with an increasing number of medical personnel ... these reasons and more, Advantage Medical Staffing, a travel nursing staffing ... a larger location. , , Advantage ...
... BUFFALO, N.Y., July 15 CTG (Nasdaq: CTGX ), ... that it was named by Healthcare Informatics to its ... Informatics 100 (HCI 100). CTG was named to the HCI 100 ... In addition to other large healthcare IT consulting firms, the list ...
... , , DALLAS, ... Enterprises, LLC announced today that the company has been awarded ... Medicaid Services (CMS) to serve as the Medicare Administrative Contractor ... The full period of contract performance is five years, including ...
... LAKE, N.J., July 15 Par Pharmaceutical Companies, Inc. (NYSE: PRX ... on Tuesday, August 4, 2009 at 9:00 am EDT to review results for ... results on August 4 before the market opens. The earnings release will be ... , Access to the live webcast can be made ...
Cached Medicine News:Health News:Proposed Water Trust Fund Bill Would Provide Solid Foundation for Improvement 2Health News:Experts to Assess Impacts and Policy Barriers to Improving Proper Medication Adherence 2Health News:Experts to Assess Impacts and Policy Barriers to Improving Proper Medication Adherence 3Health News:Experts to Assess Impacts and Policy Barriers to Improving Proper Medication Adherence 4Health News:Demand for Short-Term Medical Help Leads to Growth for Travel Nursing Staffing Agency; Prompts Move to New Location and Addition of New Online Tools for Nurses 2Health News:CTG Named to Healthcare Informatics Annual Ranking of the Top 100 Healthcare IT Providers 2Health News:CTG Named to Healthcare Informatics Annual Ranking of the Top 100 Healthcare IT Providers 3Health News:CMS Selects TrailBlazer Health Enterprises to Administer Medicare Program in Arkansas, Louisiana and Mississippi 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: